Apogee Therapeutics
@apogeetherapeutics.com
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other inflammatory and immune (I&I) diseases with high unmet need
Apogee Therapeutics's Company Logos
Apogee Therapeutics's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#099ABB
Pacific Blue
9, 154, 187
191, 91, 38
95, 18, 0, 27
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#07253B
Tiber
7, 37, 59
205, 79, 13
88, 37, 0, 77
About Apogee Therapeutics
Apogee Therapeutics, Inc. Focusing on immunological and inflammatory disorders, Apogee Therapeutics aims to develop differentiated biologics for conditions such as atopic dermatitis (AD) and chronic obstructive pulmonary disease (COPD), among others. We refuse to settle for the status quo, striving to redefine the standard of care for patients living with these diseases.
Our pipeline comprises innovative antibody therapeutics that target well-established biological drivers and developmental pathways. With a dedicated team of seasoned drug developers and operators, we are committed to providing better treatment options to individuals battling inflammatory and immune conditions. At Apogee Therapeutics, we prioritize people and cultivate an environment of psychological safety, where diverse ideas can flourish, leading to optimal outcomes.
Join us in our pursuit of advancements that enhance the lives of patients. Explore career opportunities with us today
Company type
Public Company
Year founded
2022
Company size
51-200 employees
Related Brands
Tags
Half-life-extended antibodies
Immunological and inflammatory diseases
Biotechnology drug development
Atopic dermatitis therapeutics
